Display Options:
Total: 10647
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
Small molecule
Approved
Unknown
Unknown
Gastroesophageal Reflux; Peptic Ulcer
Muscarinic acetylcholine receptor M1 antagonist
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
Small molecule
Approved
Unknown
Unknown
HIV Infections; Pruritus; Common Cold; Dry Eye Syndromes
Unknown
Combination
Approved
OTHER
ORAL
Unknown
Unknown
Unknown
Approved
OTHER
INJECTION; ORAL
Unknown
Unknown
Unknown
Approved
OTHER
INJECTION
Unknown
Unknown
Small molecule
Approved
Unknown
Unknown
Attention Deficit Disorder with Hyperactivity
Unknown
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
Small molecule
Approved
Unknown
Unknown
Adenocarcinoma of Lung; Amyotrophic Lateral Sclerosis; Bronchial Neoplasms; Glioma; Leukemia; Meningioma; Pancreatic Neoplasms; Rectal Neoplasms; Stomach Neoplasms; Adenocarcinoma, Follicular; Ameloblastoma; Breast Neoplasms; Carcinoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Cholangiocarcinoma; Colorectal Neoplasms; Erdheim-Chester Disease; Gastrointestinal Stromal Tumors; Hemangioendothelioma, Epithelioid; Histiocytosis; Leukemia, Myeloid, Acute; Lung Neoplasms; Mouth Neoplasms; Multiple Myeloma; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Uterine Cervical Neoplasms; Melanoma; Sarcoma; Thyroid Neoplasms; Neoplasms
Dual specificity mitogen-activated protein kinase kinase; MEK1/2 inhibitor
Combination
Approved
OTHER
OTIC
Unknown
Unknown
Combination
Approved
Unknown
ORAL
Unknown
Unknown
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
Protein
Approved
Unknown
Unknown
Hemophilia A
Unknown
Combination
Approved
OTHER
ORAL
Unknown
Unknown
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
Small molecule
Approved
Unknown
Unknown
Cocaine-Related Disorders; Anxiety; Dementia; Depressive Disorder; Movement Disorders; Postpoliomyelitis Syndrome; Schizophrenia; Attention Deficit Disorder with Hyperactivity
Unknown
Unknown
Approved
Unknown
Unknown
Severe Acute Respiratory Syndrome; Respiratory Distress Syndrome; Wounds and Injuries; Hemorrhage; Stomatitis
Unknown
Combination
Approved
Unknown
ORAL
Unknown
Unknown
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
Unknown
Approved
OTHER
ORAL
Unknown
Unknown
Small molecule
Approved
Unknown
Unknown
Migraine Disorders; Vertigo
Unknown
Small molecule
Approved
Unknown
Unknown
Substance-Related Disorders
Unknown
Small molecule
Unknown
Unknown
Unknown
Unknown
Unknown
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
Combination
Approved
OTHER
ORAL
Unknown
Unknown
Combination
Approved
OTHER
ORAL
Unknown
Unknown
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
Combination
Approved
CANCER; OTHER; PHARMACOLOGY
INTRAVENOUS
Unknown
Unknown
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
Small molecule
Approved
Unknown
Unknown
Unknown
GABA-A receptor; anion channel positive allosteric modulator